United Therapeutics (UTHR) stock: analyst price target and their real reliability

Live quote · data updated Aug 28, 2026
United Therapeutics · Health Care · ref. ETF XLV · 84 calls · price $527.91
🏆JPI 2026 portfoliosSee tracking →
What the company does: United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

📈 United Therapeutics (UTHR) stock price

$527.91+71.8% over range
Aug 28, 25low $304.76 · high $596.76Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
78% recommend buying · 9 analysts
📊 JPI status : United Therapeutics has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →

🎯 UTHR price target & analyst consensusprice $528

The price target · all analysts combined (9 targets)
Highest target · 1 firm of 9$738+39.8%
Median target · of 9 targets$660+25.0%
Lowest target · 1 firm of 9$519-1.7%
Current price$527.91
Where these 9 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 889% $613 ↔ $738
Below 111% $519
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: B of A Securities74% of its targets hit on this sector (105 calls tested). It aims for $613 (+16 %), call made on July 11, 2026, maturing on July 11, 2027 (48 d ago).

The 2 reliable analysts $645+22 %
The 7 other firms $660+25 %
How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $645 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 9 ratings (last 6 months)
Strong Buy00%
Buy778%
Hold222%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about United Therapeutics? The JPI assistant answers using our backtest data.

📈 United Therapeutics fundamentals: valuation, margins & growth › open the full page

P/E 18.5Net margin 41.6 %Revenue growth -1.9 %Fairly valued

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 38 %
2023
Rev +20%Profit +35%
2024
Rev +24%Profit +21%
2025
Rev +11%Profit +12%

🏛️ United Therapeutics insider buying: who's buying and how much › open the full page

1 insider bought1 buys / 6 mo $864k

🔎 Detailed analyses

✅ Historical analyst reliability on UTHR

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm % right i Gain vs sector i Calls i
Ladenburg Thalmann  100% +29.1% 8
Standpoint Research 80% +34.8% 5
Jefferies  75% +24.4% 4
Credit Suisse 73% +28.4% 11
UBS  71% +26.9% 7
Wedbush  70% +26.1% 10
Wells Fargo  67% +7.2% 3
Argus Research  60% +1.5% 5
JP Morgan  58% +27.4% 12
HC Wainwright & Co.  57% +24.6% 14
See the other 5 firms
Goldman Sachs  33% -25.1% 3
TD Cowen  50% +2.6% 2
Barclays  50% +3.1% 4
Oppenheimer  57% +10.5% 7
Morgan Stanley  57% +12.1% 7

📊 What $1,000 invested in United Therapeutics would be worth › open the full page

In short — $1,000 invested in United Therapeutics 10 years ago would be worth $3,460 today, i.e. +13%/yr on average. Best year: 2020 (+72%), worst: 2018 (-26%). Price performance, excluding dividends.

If I'd invested $1,000 in United Therapeutics

InvestmentWorth todayGain
1 years ago$1,536+54%
3 years ago$1,948+95%
5 years ago$3,570+257%
→ See United Therapeutics's full return history + gain calculator

Return by year (United Therapeutics)

YearReturn$1,000 invested at year start
2026 (YTD)+11%$1,112 (+11%)
2025+38%$1,536 (+54%)
2024+60%$2,464 (+146%)
→ See United Therapeutics's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on United Therapeutics

Loading news…

📋 All analyst calls on UTHR

RBC Capital 
Aug 6, 26
▲ Outperform · 🎯$677
Price at call : $538.84 — upside +26%
Today : $527.91 — upside +28%
🎯 on UTHR : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Aug 6, 27
JP Morgan 
Jul 23, 26
▲ Overweight · 🎯$687
Price at call : $528.47 — upside +30%
Today : $527.91 — upside +30%
🎯 on UTHR : 100% (3 calls matureds) · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Jul 23, 27
■ Neutral neutral · not a buy · 🎯$613
Price at call : $535.57 — gap to target +14%
Today : $527.91 — gap to target +16%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Jul 10, 27
RBC Capital 
Jul 7, 26
▲ Outperform · 🎯$704
Price at call : $554.34 — upside +27%
Today : $527.91 — upside +33%
🎯 on UTHR : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Jul 7, 27
RBC Capital 
May 7, 26
▲ Outperform · 🎯$701
Price at call : $564.94 — upside +24%
Today : $527.91 — upside +33%
🎯 on UTHR : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : May 7, 27
Wells Fargo 
May 7, 26
▲ Overweight · 🎯$738
Price at call : $564.94 — upside +31%
Today : $527.91 — upside +40%
🎯 on UTHR : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : May 7, 27
Morgan Stanley 
Apr 10, 26
■ Equal-Weight neutral · not a buy · 🎯$519
Price at call : $577.63 — gap to target -10%
Today : $527.91 — gap to target -2%
🎯 on UTHR : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Apr 10, 27
▲ Buy · 🎯$660
Price at call : $570.27 — upside +16%
Today : $527.91 — upside +25%
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Mar 31, 27
See the other 76 calls, newest to oldest
Wells Fargo 
Mar 31, 26
■ Equal-Weight neutral · not a buy · 🎯$575
Price at call : $570.27 — gap to target +1%
Today : $527.91 — gap to target +9%
🎯 on UTHR : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Mar 31, 27
■ Neutral neutral · not a buy · 🎯$626
Price at call : $592.98 — gap to target +6%
Today : $527.91 — gap to target +19%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Mar 31, 27
TD Cowen 
Mar 30, 26
▲ Buy · 🎯$660
Price at call : $592.98 — upside +11%
Today : $527.91 — upside +25%
🎯 on UTHR : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Mar 30, 27
Wells Fargo 
Mar 23, 26
■ Equal-Weight neutral · not a buy · 🎯$486
Price at call : $521.22 — gap to target -7%
Today : $527.91 — gap to target -8%
🎯 on UTHR : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Mar 23, 27
▲ Overweight · 🎯$625
Price at call : $536.12 — upside +17%
Today : $527.91 — upside +18%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 55.7% · +17.4% (115 calls)
in progress (365j)
matures : Mar 12, 27
UBS 
Mar 5, 26
▲ Buy · 🎯$705
Price at call : $478.16 — upside +47%
Today : $527.91 — upside +34%
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Mar 5, 27
▲ Buy · 🎯$600
Price at call : $503.9 — upside +19%
Today : $527.91 — upside +14%
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Feb 26, 27
TD Cowen 
Feb 26, 26
▲ Buy · 🎯$575
Price at call : $503.9 — upside +14%
Today : $527.91 — upside +9%
🎯 on UTHR : no call matured yet · 📊 on Health : 53.8% · +17.8% (26 calls)
in progress (365j)
matures : Feb 26, 27
Oppenheimer 
Feb 26, 26
▲ Outperform · 🎯$600
Price at call : $503.9 — upside +19%
Today : $527.91 — upside +14%
🎯 on UTHR : no call matured yet · 📊 on Health : 53.6% · +4.5% (69 calls)
in progress (365j)
matures : Feb 26, 27
RBC Capital 
Feb 26, 26
▲ Outperform · 🎯$643
Price at call : $503.9 — upside +28%
Today : $527.91 — upside +22%
🎯 on UTHR : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Feb 26, 27
Wells Fargo 
Feb 26, 26
■ Equal-Weight neutral · not a buy · 🎯$466
Price at call : $503.9 — gap to target -8%
Today : $527.91 — gap to target -12%
🎯 on UTHR : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Feb 26, 27
UBS 
Jan 6, 26
▲ Buy · 🎯$645
Price at call : $503.69 — upside +28%
Today : $527.91 — upside +22%
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Jan 6, 27
UBS 
Nov 6, 25
▲ Buy · 🎯$600
Price at call : $448.91 — upside +34%
Today : $527.91 — upside +14%
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Nov 6, 26
▲ Buy · 🎯$525
Price at call : $445.43 — upside +18%
Today : $527.91 — upside -1%
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Oct 30, 26
RBC Capital 
Oct 30, 25
▲ Outperform · 🎯$587
Price at call : $445.43 — upside +32%
Today : $527.91 — upside +11%
🎯 on UTHR : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Oct 30, 26
Wells Fargo 
Oct 30, 25
■ Equal-Weight neutral · not a buy · 🎯$423
Price at call : $445.43 — gap to target -5%
Today : $527.91 — gap to target -20%
🎯 on UTHR : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Oct 30, 26
Morgan Stanley 
Oct 10, 25
■ Equal-Weight neutral · not a buy · 🎯$435
Price at call : $440.06 — gap to target -1%
Today : $527.91 — gap to target -18%
🎯 on UTHR : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Oct 10, 26
UBS 
Sep 29, 25
▲ Buy · 🎯$580
Price at call : $419.21 — upside +38%
Today : $527.91 — upside +10%
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Sep 29, 26
RBC Capital 
Sep 26, 25
▲ Outperform · 🎯$569
Price at call : $432.66 — upside +32%
Today : $527.91 — upside +8%
🎯 on UTHR : no call matured yet · 📊 on Health : 49.2% · +7.0% (195 calls)
in progress (365j)
matures : Sep 26, 26
▲ Overweight · 🎯$525
Price at call : $396.5 — upside +32%
Today : $527.91 — upside -1%
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 55.7% · +17.4% (115 calls)
in progress (365j)
matures : Sep 10, 26
Oppenheimer 
Sep 5, 25
▲ Outperform · 🎯$575
Price at call : $394.62 — upside +46%
Today : $527.91 — upside +9%
🎯 on UTHR : no call matured yet · 📊 on Health : 53.6% · +4.5% (69 calls)
in progress (365j)
matures : Sep 5, 26
▲ Buy · 🎯$500
Price at call : $400.52 — upside +25%
Today : $527.91 — upside -5%
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
in progress (365j)
matures : Sep 5, 26
UBS 
Sep 4, 25
▲ Buy · 🎯$560
Price at call : $380.47 — upside +47%
Today : $527.91 — upside +6%
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Sep 4, 26
Wells Fargo 
Sep 3, 25
■ Equal-Weight neutral · not a buy · 🎯$414
Price at call : $391.45 — gap to target +6%
Today : $527.91 — gap to target -22%
🎯 on UTHR : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Sep 3, 26
Jefferies 
Sep 2, 25
▲ Buy · 🎯$564
Price at call : $391.45 — upside +44%
Today : $527.91 — upside +7%
🎯 on UTHR : no call matured yet · 📊 on Health : 49.1% · +10.3% (112 calls)
in progress (365j)
matures : Sep 2, 26
■ Neutral neutral · not a buy · 🎯$463
Price at call : $391.45 — gap to target +18%
Today : $527.91 — gap to target -12%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Sep 2, 26
UBS 
Aug 13, 25
▲ Buy · 🎯$415
Price at call : $309.72 — upside +34%
Today : $527.91 — upside -21%
Expected +34% · Actual +62% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+61.9%
stock +62% · XLV +26%
matured Aug 13, 26
Wells Fargo 
Jul 31, 25
■ Equal-Weight neutral · not a buy · 🎯$295
Price at call : $294.28 — gap to target +0%
Today : $527.91 — gap to target -44%
🎯 on UTHR : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Jul 31, 26
▲ Buy · 🎯$400
Price at call : $274.7 — upside +46%
Today : $527.91 — upside -24%
Expected +46% · Actual +88% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+88.5%
stock +88% · XLV +25%
matured Jul 31, 26
Morgan Stanley 
Jul 10, 25
■ Equal-Weight neutral · not a buy · 🎯$328
Price at call : $295.52 — gap to target +11%
Today : $527.91 — gap to target -38%
🎯 on UTHR : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Jul 10, 26
JP Morgan 
Jul 8, 25
▲ Overweight · 🎯$330
Price at call : $300.56 — upside +10%
Today : $527.91 — upside -37%
Expected +10% · Actual +84% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (3 calls matureds) · 📊 on Health : 49.3% · +6.2% (142 calls)
+83.8%
stock +84% · XLV +20%
matured Jul 8, 26
UBS 
Jun 30, 25
▲ Buy · 🎯$385
Price at call : $290.91 — upside +32%
Today : $527.91 — upside -27%
Expected +32% · Actual +88% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (2 calls matureds) · 📊 on Health : 49.6% · +18.1% (119 calls)
+88.1%
stock +88% · XLV +17%
matured Jun 30, 26
■ Neutral neutral · not a buy · 🎯$315
Price at call : $286.14 — gap to target +10%
Today : $527.91 — gap to target -40%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Jun 11, 26
▲ Overweight · 🎯$405
Price at call : $324.2 — upside +25%
Today : $527.91 — upside -23%
Expected +25% · Actual +69% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 55.7% · +17.4% (115 calls)
+69.5%
stock +69% · XLV +11%
matured Jun 2, 26
▲ Buy · 🎯$425
Price at call : $298.7 — upside +42%
Today : $527.91 — upside -19%
Expected +42% · Actual +92% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+91.6%
stock +92% · XLV +5%
matured May 5, 26
JP Morgan 
May 1, 25
▲ Overweight · 🎯$350
Price at call : $294.6 — upside +19%
Today : $527.91 — upside -34%
Expected +19% · Actual +97% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (3 calls matureds) · 📊 on Health : 49.3% · +6.2% (142 calls)
+97.3%
stock +97% · XLV +4%
matured May 1, 26
■ Equal-Weight neutral · not a buy · 🎯$348
Price at call : $294.6 — gap to target +18%
Today : $527.91 — gap to target -34%
🎯 on UTHR : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : May 1, 26
■ Neutral neutral · not a buy · 🎯$321
Price at call : $293.85 — gap to target +9%
Today : $527.91 — gap to target -39%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : May 1, 26
Wells Fargo 
Apr 25, 25
■ Equal-Weight neutral · not a buy · 🎯$314
Price at call : $291.38 — gap to target +8%
Today : $527.91 — gap to target -41%
🎯 on UTHR : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Apr 25, 26
JP Morgan 
Apr 21, 25
▲ Overweight · 🎯$355
Price at call : $292.82 — upside +21%
Today : $527.91 — upside -33%
Expected +21% · Actual +96% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (3 calls matureds) · 📊 on Health : 49.3% · +6.2% (142 calls)
+96.1%
stock +96% · XLV +8%
matured Apr 21, 26
■ Neutral neutral · not a buy · 🎯$314
Price at call : $284.25 — gap to target +10%
Today : $527.91 — gap to target -41%
🎯 on UTHR : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : Apr 21, 26
▲ Buy · 🎯$425
Price at call : $323.62 — upside +31%
Today : $527.91 — upside -19%
Expected +31% · Actual +56% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+55.7%
stock +56% · XLV +9%
matured Feb 27, 26
▲ Buy · 🎯$344
Price at call : $374.02 — upside -8%
Today : $527.91 — upside -35%
Expected -8% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+17.3%
stock +17% · XLV -2%
matured Oct 31, 25
Argus Research 
Oct 31, 24
▲ Buy · 🎯$400
Price at call : $374.02 — upside +7%
Today : $527.91 — upside -24%
Expected +7% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
+17.3%
stock +17% · XLV -2%
matured Oct 31, 25
▲ Buy · 🎯$425
Price at call : $374.02 — upside +14%
Today : $527.91 — upside -19%
Expected +14% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+17.3%
stock +17% · XLV -2%
matured Oct 31, 25
▲ Buy · 🎯$400
Price at call : $327.79 — upside +22%
Today : $527.91 — upside -24%
Expected +22% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-10.2%
stock -10% · XLV -13%
matured Aug 1, 25
▲ Buy · 🎯$400
Price at call : $336.37 — upside +19%
Today : $527.91 — upside -24%
Expected +19% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-9.5%
stock -9% · XLV -8%
matured Jul 25, 25
▲ Buy · 🎯$300
Price at call : $258.13 — upside +16%
Today : $527.91 — upside -43%
Expected +16% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+14.1%
stock +14% · XLV -1%
matured May 2, 25
Wedbush 
Feb 22, 24
▲ Outperform · 🎯$308
Price at call : $217.6 — upside +42%
Today : $527.91 — upside -42%
Expected +42% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+66.0%
stock +66% · XLV -1%
matured Feb 21, 25
▲ Buy · 🎯$300
Price at call : $217.6 — upside +38%
Today : $527.91 — upside -43%
Expected +38% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+66.0%
stock +66% · XLV -1%
matured Feb 21, 25
▲ Outperform · 🎯$330
Price at call : $212.76 — upside +55%
Today : $527.91 — upside -37%
Expected +55% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
+66.1%
stock +66% · XLV +3%
matured Feb 4, 25
Wedbush 
Nov 2, 23
▲ Outperform · 🎯$308
Price at call : $228.18 — upside +35%
Today : $527.91 — upside -42%
Expected +35% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+63.9%
stock +64% · XLV +17%
matured Nov 1, 24
▲ Buy · 🎯$268
Price at call : $231.87 — upside +16%
Today : $527.91 — upside -49%
Expected +16% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+41.3%
stock +41% · XLV +14%
matured Aug 2, 24
Wedbush 
Aug 3, 23
▲ Outperform · 🎯$307
Price at call : $231.87 — upside +32%
Today : $527.91 — upside -42%
Expected +32% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+41.3%
stock +41% · XLV +14%
matured Aug 2, 24
▲ Buy · 🎯$300
Price at call : $231.87 — upside +29%
Today : $527.91 — upside -43%
Expected +29% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
+41.3%
stock +41% · XLV +14%
matured Aug 2, 24
▲ Buy · 🎯$256
Price at call : $215.72 — upside +19%
Today : $527.91 — upside -52%
Expected +19% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+21.6%
stock +22% · XLV +6%
matured May 3, 24
Argus Research 
Apr 21, 23
▲ Buy · 🎯$280
Price at call : $230.76 — upside +21%
Today : $527.91 — upside -47%
Expected +21% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
+1.4%
stock +1% · XLV +4%
matured Apr 20, 24
▲ Buy · 🎯$300
Price at call : $248.36 — upside +21%
Today : $527.91 — upside -43%
Expected +21% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-8.6%
stock -9% · XLV +14%
matured Feb 23, 24
Argus Research 
Jan 11, 23
▲ Buy · 🎯$300
Price at call : $263.79 — upside +14%
Today : $527.91 — upside -43%
Expected +14% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
-16.5%
stock -16% · XLV +4%
matured Jan 11, 24
▲ Buy · 🎯$300
Price at call : $265.42 — upside +13%
Today : $527.91 — upside -43%
Expected +13% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-15.4%
stock -15% · XLV -2%
matured Nov 3, 23
Wedbush 
May 24, 22
▲ Outperform · 🎯$263
Price at call : $218.95 — upside +20%
Today : $527.91 — upside -50%
Expected +20% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
-2.2%
stock -2% · XLV -2%
matured May 24, 23
▲ Buy · 🎯$255
Price at call : $218.95 — upside +16%
Today : $527.91 — upside -52%
Expected +16% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 58% (12 calls matureds) · 📊 on Health : 68.1% · +24.0% (238 calls)
-2.2%
stock -2% · XLV -2%
matured May 24, 23
Wedbush 
Feb 28, 22
▲ Outperform · 🎯$236
Price at call : $166.2 — upside +42%
Today : $527.91 — upside -55%
Expected +42% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+48.0%
stock +48% · XLV -2%
matured Feb 28, 23
▲ Buy · 🎯$203
Price at call : $166.2 — upside +22%
Today : $527.91 — upside -62%
Expected +22% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+48.6%
stock +49% · XLV -1%
matured Feb 25, 23
Argus Research 
Jul 14, 21
▲ Buy · 🎯$205
Price at call : $183.59 — upside +12%
Today : $527.91 — upside -61%
Expected +12% · Actual +29% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
+29.2%
stock +29% · XLV -1%
matured Jul 14, 22
Wedbush 
Jul 30, 20
▲ Outperform · 🎯$244
Price at call : $113.5 — upside +115%
Today : $527.91 — upside -54%
Expected +115% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+60.3%
stock +60% · XLV +25%
matured Jul 30, 21
▲ Buy · 🎯$106
Price at call : $83.07 — upside +28%
Today : $527.91 — upside -80%
Expected +28% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+34.2%
stock +34% · XLV +16%
matured Jul 31, 20
Wedbush 
May 2, 19
▲ Outperform · 🎯$273
Price at call : $101.25 — upside +170%
Today : $527.91 — upside -48%
Expected +170% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+7.8%
stock +8% · XLV +9%
matured May 1, 20
Wedbush 
Aug 2, 18
▲ Outperform · 🎯$253
Price at call : $123.24 — upside +105%
Today : $527.91 — upside -52%
Expected +105% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
-32.4%
stock -32% · XLV +2%
matured Aug 2, 19
▲ Buy
Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+1.5%
stock +1% · XLV +20%
matured Oct 28, 17
■ Neutral neutral · not a buy
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
in progress (365j)
matures : Apr 29, 17
Wedbush 
Aug 20, 15
▲ Outperform · 🎯$244
Price at call : $162.66 — upside +50%
Today : $527.91 — upside -54%
Expected +50% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
-22.0%
stock -22% · XLV +1%
matured Aug 19, 16
Argus Research 
Mar 12, 15
▲ Buy
Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on UTHR : 60% (5 calls matureds) · 📊 on Health : 41.7% · +1.1% (12 calls)
-23.7%
stock -24% · XLV -5%
matured Mar 11, 16
Wedbush 
Aug 29, 14
▲ Outperform · 🎯$141
Price at call : $115.22 — upside +22%
Today : $527.91 — upside -73%
Expected +22% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 70% (10 calls matureds) · 📊 on Health : 39.4% · -0.3% (33 calls)
+30.7%
stock +31% · XLV +10%
matured Aug 29, 15
▲ Buy · 🎯$138
Price at call : $112.85 — upside +22%
Today : $527.91 — upside -74%
Expected +22% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+15.4%
stock +15% · XLV +25%
matured Dec 23, 14
▲ Buy · 🎯$58
Price at call : $43.75 — upside +33%
Today : $527.91 — upside -89%
Expected +33% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on UTHR : 100% (8 calls matureds) · 📊 on Health : 77.8% · +22.6% (9 calls)
+52.6%
stock +53% · XLV +26%
matured Apr 30, 13

Frequently asked questions

Should I buy United Therapeutics stock?

This isn't buy advice. For United Therapeutics, the analyst consensus is "Buy", with an average price target of $660 (+25% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (8 calls tracked on United Therapeutics). We show the numbers — you decide.

Is it too late to buy United Therapeutics? How high can it go?

The most bullish analyst target on United Therapeutics is $738 (+40% above today's price); the average is $660. That's the upside they see. Check how reliable those analysts have actually been on United Therapeutics on our site before trusting it.

Is United Therapeutics still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 15 analysts have a real record on United Therapeutics, the best hitting 100% over 8 calls. Current consensus: "Buy". Make your call on data, not noise.

Should you invest in United Therapeutics? The case for and against

The arguments for and against, one by one, from the numbers: why invest in UTHR (and why hesitate).

What has United Therapeutics's past performance been?

Historical returns and a "how much if I had invested" calculator: UTHR performance & returns.

What is the best month to buy UTHR?

The 12 months ranked by the stock's past returns: best & worst month to buy UTHR.

Are insiders buying UTHR stock?

Executives' and large holders' buys and sells, decoded: insider buying on UTHR.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)